Company Overview
ViaCord
Cord Blood Registry
CryoCell
Ownership
Revvity
The Cooper Companies
Cryo-Cell International, Inc.
Portfolio
Healthcare: Diagnostics & Research
Healthcare: Medical Instruments & Supplies
Healthcare: Medical Care Facilities
Business Structure
Public Company, NYSE: RVTY
Public Company, NYSE: COO
Public Company, NYSE: CCEL
Ownership Changes
Last 10 Years
4
Sustained Profitability
5+ Consecutive Years of Profitability
Yes
Unknown - Not Publicly Available pre-2021
No
Business Transparency
ViaCord
Cord Blood Registry
CryoCell
Cord Blood Processing Results
✔
✔
✔
Discloses Results of Units Released
For Transplants
✔
X
X
Annual Storage Fee Increases
Last 5 Years
1
5
2
Financial Performance
✔
X
✔
Laboratory Credentials
ViaCord
Cord Blood Registry
CryoCell
CLIA Certified
✔
✔
X
FDA Registered
✔
✔
✔
AABB Accredited for Cord Blood
✔
✔
✔
AABB Accredited For Cord Tissue
✔
X
X
Cord Blood Overview
ViaCord
Cord Blood Registry
CryoCell
Significant Processing Experience
✔
✔
✔
Units Released For Transplants
> 500
> 500
< 150
Transplant Survival Rate
> 80%
Not disclosed
Not disclosed
Quality Product Guarantee
✔
✔
✔
5-Compartment Multi-
Use Storage Bag
✔
X
✔
Optional Genomic Testing
✔
X
X
Cord Tissue Overview
ViaCord
Cord Blood Registry
CryoCell
Saves All Cell Types
✔
✔
✔
5-Compartment Multi-
Use Storage Bag
✔
X
X
Processes and Extracts
Cells Before Storage
✔
X
X
AABB Accredited
✔
X
X
Cell Processing Method Established
✔
X
X
Standard Service Includes
Cost To Extract Cord Tissue Cells
✔
X
X
Fees Overview
ViaCordFguar
Cord Blood Registry
CryoCell
Processing Fee (Year 1)
Cord Blood & Cord Tissue Processing
$1230
$2625
$2470
Shipping Fee
N/A
$170
N/A
Annual Storage Fee
Cord Blood & Cord Tissue
$370
$400
$370
